AUPH: Aurinia Pharmaceuticals Inc. Stock

by  •  • Comments Off on AUPH: Aurinia Pharmaceuticals Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 727.43
Enterprise Value ($M) 678.67
Book Value ($M) 377.95
Book Value / Share 2.61
Price / Book 1.92
NCAV ($M) 254.69
NCAV / Share 1.76
Price / NCAV 2.86

Profitability (mra)
Return on Invested Capital (ROIC) -0.16
Return on Assets (ROA) -0.17
Return on Equity (ROE) -0.20

Liquidity (mrq)
Quick Ratio 4.99
Current Ratio 5.50

Balance Sheet (mrq) ($M)
Current Assets 424.80
Assets 548.06
Liabilities 170.11
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 175.51
Operating Income -85.79
Net Income -78.02

Cash Flow Statement (mra) ($M)
Cash From Operations -33.46
Cash from Investing -6.71
Cash from Financing -5.13

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
03-20 13D/A ILJIN SNT Co., Ltd. 5.20 4.96
02-14 13G Armistice Capital, Llc 6.64
02-12 13G/A BlackRock Inc. 6.20 9.19

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-02-15 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K ☑ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SE
2023-11-02 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2023-08-03 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2023-05-04 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-04-25 301,020 1,370,533 21.96
2024-04-24 178,195 222,867 79.96
2024-04-23 241,991 269,372 89.84
2024-04-22 175,643 329,322 53.33

(click for more detail)

Similar Companies
ARDX – Ardelyx, Inc. ATAI – Atai Life Sciences N.V.
ATXS – Astria Therapeutics, Inc. AURA – Aura Biosciences, Inc.
AVBP – ArriVent BioPharma, Inc.


Financial data and stock pages provided by
Fintel.io

Finpedia: Aurinia Pharmaceuticals